Australia requires less evidence for premarket application audits
This article was originally published in SRA
Australia’s Therapeutic Goods Administration has reduced the amount of documentary evidence it requires from medical device sponsors applying for premarket application audits in an effort to decrease the existing backlog of applications1. An application audit confirms that a device manufacturer has carried out the conformity assessment procedures appropriate to the class of device.
You may also be interested in...
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.
A first-of-its-kind collaborative study has found that real-world and natural history data are comparable to placebo data from clinical trials in Duchenne muscular dystrophy.
An EU group has listed several ambitious projects to help EU regulators realize their cherished vision of using big data capabilities to support innovation and public health. But these proposals may take a backseat as COVID-19-related challenges continue.